Can India’s ‘Borrow And Treat’ Market Move The Access Needle?
This article was originally published in PharmAsia News
Are innovative financing schemes to improve access to breakthrough, expensive drugs the way forward in self-pay emerging markets like India? And can microfinance firms move the needle in such markets marked by low health insurance penetration?
Register for our free email digests: